GlassScriptPhysician profile
Anthony J Vecchiarelli
NPI 1508062217
$703.16
in general payments reported to CMS, 2019-2025
18 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.09 · 2020: $24.86 · 2021: $116 · 2022: $89.07 · 2023: $142 · 2024: $72.65 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $95.44 | 2024-2025 | Airsupra |
| Abbvie INC. | $80.96 | 2019-2023 | Vraylar |
| Pfizer INC. | $79.70 | 2023-2024 | |
| Allergan, INC. | $43.11 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $42.82 | 2021 | |
| Seqirus USA INC | $41.85 | 2024-2025 | Flucelvax, Fluad |
| Medtronic, INC. | $38.95 | 2025 | Symplicity G3 |
| Eisai INC. | $37.34 | 2021 | |
| Novo Nordisk INC | $36.64 | 2024-2025 | Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $36.45 | 2022 | |
| Janssen Pharmaceuticals, INC | $30.14 | 2023 | Spravato |
| Therapeuticsmd, INC. | $30.10 | 2019-2021 | |
| Inspire Medical Systems, INC. | $22.35 | 2025 | Inspire |
| Alfasigma USA, INC. | $21.03 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $19.77 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $17.57 | 2025 | |
| Amgen INC. | $14.91 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $14.03 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Vecchiarelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.